Lateral Flow Immuno Assays
At Fortis Life Science, we are a full-service lateral flow immunoassay development company specializing in the design and manufacture of diagnostic assays. Whether you are a global IVD company or a virtual start-up, developing and commercializing a lateral flow assay can present many challenges.
Our team works as an experienced partner to assist you with a range of services that span all phases of the development cycle, offering industry-leading technologies for increasing assay sensitivity as well as the tools and information required to make your next lateral flow immunoassay product a success.
Lateral flow assays - sometimes referred to as immunoassays or rapid tests - are diagnostic devices that are used to detect the presence, or confirm the absence of target analytes within a liquid sample.
Lateral flow tests are widely used in diagnostic testing, often used at patients at home as well as by professionals in laboratory settings.
Lateral Flow Immunoassays Resources
- Introduction to Lateral Flow Rapid Test Diagnostics
- Design Cycle of Lateral Flow Immunoassays
- A Guide to Lateral Flow Assay Design & Requirements
- Antibody Selection and Purification for Lateral Flow Rapid Tests
- Reporter Nanoparticle Selection for Lateral Flow Immunoassays
- Passive Nanoparticle Conjugation for Lateral Flow Assays
- Covalent Conjugation of Antibody to Gold Nanoparticles for Lateral Flow Assays
- Interpreting Particle Spectra During Protein Conjugation
- Conjugate Pad Selection, Treatment, and Conjugate Drying for Lateral Flow Assays
- Nitrocellulose Membrane Selection and Striping for Lateral Flow Assays
- Sample and Absorbent Pad Selection for Lateral Flow Assays
- Lateral Flow Test Strip Assembly
- Test Methods to Measure the Performance of Lateral Flow Assays Prototypes
- Lateral Flow Rapid Test Assay Optimization
- Lateral Flow Tips, Tricks and Frequently Asked Questions
Lateral Flow FAQs
Our 150 nm ultra-bright Gold Nanoshells offer up to a 20x sensitivity enhancement compared to 40 nm gold nanoparticles. Click here to learn more.
BioReady NHS Gold Nanospheres and Nanoshells can be covalently conjugated to primary amines (-NH2) of proteins in a simplified procedure compared to the carboxyl surface. These nanoparticles are surface functionalized with an active NHS ester to generate gold nanoparticle-antibody amide bonds, eliminating the need for the user to perform the intermediary EDC/Sulfo-NHS chemistry steps. The particles are supplied as a lyophilized powder that can be resuspended with a buffer to covalently bind to an added antibody. This coupling reaction is rapid, simple, robust, and requires little optimization.
For a complete list of items included in our covalent (carboxyl-functionalized) conjugation kits, follow the links below:
We sure do! Follow the link to view our library of Protocols & White Papers.
By clicking “Acknowledge”, you consent to our website's use of cookies to give you the most relevant experience by remembering your preferences and to analyze our website traffic.
